Systematic review of complications of prostate biopsy.
Stacy Loeb,Annelies Vellekoop,Hashim U. Ahmed,James W.F. Catto,Mark Emberton,Robert K. Nam,Derek J. Rosario,Vincenzo Scattoni,Yair Lotan +8 more
TLDR
Preparation for biopsy should include antimicrobial prophylaxis and pain management, and infectious complications are increasing over time and are the most common reason for hospitalization after biopsy.About:
This article is published in European Urology.The article was published on 2013-12-01 and is currently open access. It has received 802 citations till now. The article focuses on the topics: Prostate biopsy & Lower urinary tract symptoms.read more
Citations
More filters
Journal ArticleDOI
EAU–ESTRO–SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more
TL;DR: The 2016 EAU-STRO-IOG Prostate Cancer (PCa) Guidelines present updated information on the diagnosis, and treatment of clinically localised prostate cancer and reflect the multidisciplinary nature of PCa management.
Journal ArticleDOI
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed,Hashim U. Ahmed,Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Louise Brown,Rhian Gabe,Richard Kaplan,Mahesh K.B. Parmar,Yolanda Collaco-Moraes,Katie Ward,Richard Hindley,Alex Freeman,Alex Kirkham,Robert Oldroyd,Chris Parker,Mark Emberton,Mark Emberton +16 more
TL;DR: Using MP-MRI to triage men might allow 27% of patients avoid a primary biopsy and diagnosis of 5% fewer clinically insignificant cancers, as well as reduce unnecessary biopsies by a quarter.
Journal ArticleDOI
Clinical practice guidelines in oncology
William J. Gradishar,Benjamin O. Anderson,Ron Balassanian,Sarah L. Blair,Harold J. Burstein,Amy E. Cyr,Anthony D. Elias,William B. Farrar,Andres Forero,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Steven J. Isakoff,Janice A. Lyons,P. Kelly Marcom,Ingrid A. Mayer,Beryl McCormick,Meena S. Moran,Ruth O'Regan,Sameer A. Patel,Lori J. Pierce,Elizabeth C. Reed,Kilian E. Salerno,Lee S. Schwartzberg,Amy Sitapati,Karen L. Smith,Mary Lou Smith,Hatem Soliman,George Somlo,Melinda L. Telli,John H. Ward,Rashmi Kumar,Dorothy A. Shead +32 more
TL;DR: This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Journal ArticleDOI
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schröder,Jonas Hugosson,Monique J. Roobol,Teuvo L.J. Tammela,Marco Zappa,Vera Nelen,Maciej Kwiatkowski,Marcos Lujan,Liisa Määttänen,Hans Lilja,Louis Denis,Franz Recker,Alvaro Paez,Chris H. Bangma,Sigrid Carlsson,Sigrid Carlsson,Donella Puliti,Arnauld Villers,Xavier Rebillard,Matti Hakama,Ulf-Håkan Stenman,Paula Kujala,Kimmo Taari,Gunnar Aus,Andreas R. Huber,Theo van der Kwast,Ron H.N. van Schaik,Harry J. de Koning,Sue Moss,Anssi Auvinen +29 more
TL;DR: In this update the ERSPC confirms a substantial reduction in prostate cancer mortality attributable to testing of PSA, with a substantially increased absolute effect at 13 years compared with findings after 9 and 11 years.
Guidelines on Prostate Cancer
Axel Heidenreich,Joaquim Bellmunt,Michel Bolla,Steven Joniau,Vsevolod Matveev,N. Mottet,Thomas Wiegel,Filiberto Zattoni +7 more
TL;DR: The introduction of an effective blood test, prostate specific antigen (PSA), has made it possible to diagnose more and more men in an earlier stage where they can be offered potentially curative treatments, and this is the subject of the EAU guidelines on prostate cancer.
References
More filters
Journal ArticleDOI
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis
J. Stuart Wolf,Carol J. Bennett,Roger Dmochowski,Brent K. Hollenbeck,Margaret S. Pearle,Anthony J. Schaeffer +5 more
TL;DR: Recommendations provided in this document can assist urologists in the appropriate use of periprocedural antimicrobial prophylaxis in order to reduce the risk of postprocedural local and systemic infections.
Journal ArticleDOI
Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis.
Michael Valet,Till Sprenger,Henning Boecker,Frode Willoch,Ernst J. Rummeny,Bastian Conrad,Peter Erhard,Thomas R. Tölle +7 more
TL;DR: According to the results, the cingulo‐frontal cortex may exert top–down influences on the PAG and posterior thalamus to gate pain modulation during distraction, which is associated with a significant reduction of the visual analogue scale (VAS) ratings for pain intensity and unpleasantness.
Journal ArticleDOI
Complications After Prostate Biopsy: Data From SEER-Medicare
TL;DR: Infectious complications after prostate biopsy have increased in recent years while the rate of serious noninfectious complications is relatively stable, and among men undergoing biopsy, later year, nonwhite race and higher comorbidity scores were significantly associated with an increased risk of infectious complications.
Journal ArticleDOI
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
Robert K. Nam,Robert K. Nam,Refik Saskin,Yuna Lee,Ying Liu,Calvin Law,Calvin Law,Laurence Klotz,D. Andrew Loblaw,John Trachtenberg,Aleksandra Stanimirovic,Andrew E. Simor,Arun Seth,David R. Urbach,David R. Urbach,Steven A. Narod +15 more
TL;DR: The hospital admission rates for complications following transrectal ultrasound guided prostate biopsy have increased dramatically during the last 10 years primarily due to an increasing rate of infection related complications.
Journal ArticleDOI
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program
TL;DR: Assessment of the risk factors before biopsy can help to improve the adequacy of counseling, and precautionary measures can be taken to minimize the risk of complications after the procedure.
Related Papers (5)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan,Antti Rannikko,Marcelo Borghi,Valeria Panebianco,Lance A. Mynderse,Markku H. Vaarala,Alberto Briganti,Lars Budäus,Giles Hellawell,Richard G. Hindley,Monique J. Roobol,Scott E. Eggener,Maneesh Ghei,Arnauld Villers,Franck Bladou,Geert M. Villeirs,Jaspal Virdi,S. Boxler,Grégoire Robert,Paras B. Singh,Wulphert Venderink,Boris Hadaschik,Alain Ruffion,Jim C. Hu,Daniel Margolis,Sebastien Crouzet,Laurence Klotz,Samir S. Taneja,Peter A. Pinto,Inderbir S. Gill,Clare Allen,Francesco Giganti,Alex Freeman,Stephen Morris,Shonit Punwani,Norman R. Williams,Chris Brew-Graves,Jonathan J Deeks,Yemisi Takwoingi,Mark Emberton,Caroline M. Moore +40 more
EAU–ESTRO–SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more